Skip to main content

Cording following treatment for breast cancer

Abstract

Treatment for breast cancer may result in the formation of palpable cords in the axillary region. Our aim was to evaluate cording incidence, risk factors, and association with upper extremity functional impairment and measured arm volume change. We included 308 patients with unilateral breast cancer prospectively screened for upper extremity lymphedema, symptoms and function. Patients were assessed pre- and post-operatively and at 3–8-month intervals with perometer arm measurements and the LEFT-BC questionnaire. Cording was determined by patient self-report. The cumulative incidence of cording and its association with clinicopathologic factors, upper extremity functional impairment, and measured arm volume change were analyzed. 31.5 % (97/308) of patients reported cording, with a cumulative incidence of 36.2 % at 24 months post-operative. Clinicopathologic factors significantly associated with cording by multivariate analysis included axillary lymph node dissection (p < 0.0001) and younger age at diagnosis (p = 0.0005). Cording was associated with increased functional impairment (p = 0.0018) and an arm volume increase of ≥5 % (p = 0.028). Cording following breast cancer treatment is common, and may occur beyond the post-operative period. Our findings emphasize the importance of identifying patients at high risk for cording, and developing strategies to minimize functional impairment and arm volume elevation associated with cording. Future studies should investigate the effectiveness of interventions for cording following breast cancer treatment.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Bergmann A, Mendes VV, de Almeida Dias R, do Amaral E Silva B, da Costa Leite Ferreira MG, Fabro EA (2012) Incidence and risk factors for axillary web syndrome after breast cancer surgery. Breast Cancer Res Treat 131(3):987–992

    PubMed  Article  Google Scholar 

  2. Leduc O, Sichere M, Moreau A, Rigolet J, Tinlot A, Darc S, Wilputte F, Strapart J, Parijs T, Clement A, Snoeck T, Pastouret F, Leduc A (2009) Axillary web syndrome: nature and localization. Lymphology 42(4):176–181

    PubMed  CAS  Google Scholar 

  3. Moskovitz AH, Anderson BO, Yeung RS, Byrd DR, Lawton TJ, Moe RE (2001) Axillary web syndrome after axillary dissection. Am J Surg 181(5):434–439

    PubMed  Article  CAS  Google Scholar 

  4. Leidenius M, Leppanen E, Krogerus L, von Smitten K (2003) Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185(2):127–130

    PubMed  Article  Google Scholar 

  5. Lauridsen MC, Christiansen P, Hessov IB (2005) The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study. Acta Oncol 44(5):449–457

    PubMed  Article  Google Scholar 

  6. Torres Lacomba M, Mayoral Del Moral O, Coperias Zazo JL, Yuste Sánchez MJ, Ferrandez JC, Zapico Goñi A (2009) Axillary web syndrome after axillary dissection in breast cancer: a prospective study. Breast Cancer Res Treat 117(3):625–630

    PubMed  Article  Google Scholar 

  7. Pappo I, Wasserman I, Stahl-Kent V, Sandbank J, Halevy A (2004) Mondor’s disease of the axilla: a rare complication of sentinel node biopsy. Breast J 10(3):253–255

    PubMed  Article  Google Scholar 

  8. Ferreira Rezende L, Laier Franco R, Costa Gurgel MS (2005) Axillary web syndrome: practical implications. Breast J 11(6):531

    Article  Google Scholar 

  9. Rashtak S, Gamble GL, Gibson LE, Pittelkow MR (2012) From furuncle to axillary web syndrome: shedding light on histopathology and pathogenesis. Dermatology 224(2):110–114

    PubMed  Article  Google Scholar 

  10. Alvarez-Garrido H, Garrido-Rios AA, Sanz-Munoz C, Miranda-Romero A (2009) Mondor’s disease. Clin Exp Dermatol 34(7):753–756

    PubMed  Article  CAS  Google Scholar 

  11. Morehead-Gee AJ, Pfalzer L, Levy E, McGarvey C, Springer B, Soballe P, Gerber L, Stout NL (2012) Racial disparities in physical and functional domains in women with breast cancer. Support Care Cancer 20(8):1839–1847

    PubMed  Article  Google Scholar 

  12. Armer JM, Radina ME, Porock D, Culbertson SD (2003) Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52(6):370–379

    PubMed  Article  Google Scholar 

  13. Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C (2001) Measuring the whole or the parts? Validity, reliability, and responsiveness of the disabilities of the arm, shoulder and hand outcome measure in different regions of the upper extremity. J Hand Ther 14(2):128–146

    PubMed  Article  CAS  Google Scholar 

  14. Ancukiewicz M, Russell TA, Otoole J, Specht M, Singer M, Kelada A et al (2011) Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 79(5):1436–1443

    PubMed  Article  Google Scholar 

  15. Coen JJ, Taghian AG, Kachnic LA, Assaad SI, Powell SN (2003) Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 55(5):1209–1215

    PubMed  Article  Google Scholar 

  16. Hayes SB, Freedman GM, Li T, Anderson PR, Ross E (2008) Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? Int J Radiat Oncol Biol Phys 72(5):1449–1455

    PubMed  Article  Google Scholar 

  17. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16(7):1959–1972

    PubMed  Article  Google Scholar 

  18. Cormier JN, Xing Y, Zaniletti I, Askew RL, Stewart BR, Armer JM (2009) Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology 42(4):161–175

    PubMed  CAS  Google Scholar 

  19. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112(12):2809–2819

    PubMed  Article  Google Scholar 

  20. Boccardo FM, Ansaldi F, Bellini C, Accogli S, Taddei G, Murdaca G et al (2009) Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology 42(1):1–9

    PubMed  CAS  Google Scholar 

  21. National Lymphedema Network Medical Advisory Committee (2012) Supplement to NLN position breast cancer screening: screening and early detection of breast cancer-related lymphedema: the imperative. National Lymphedema Network

  22. Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A et al (2010) Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 340:b5396

    PubMed  Article  Google Scholar 

  23. Rockson SG (1998) Precipitating factors in lymphedema: myths and realities. Cancer 83(12 Suppl American):2814–2816

    PubMed  Article  CAS  Google Scholar 

  24. Petrek JA, Pressman PI, Smith RA (2000) Lymphedema: current issues in research and management. CA Cancer J Clin 50(5):292–307

    Article  CAS  Google Scholar 

  25. Cheville AL, Tchou J (2007) Barriers to rehabilitation following surgery for primary breast cancer. J Surg Oncol 95(5):409–418

    PubMed  Article  Google Scholar 

  26. Wyrick SL, Waltke LJ, Ng AV (2006) Physical therapy may promote resolution of lymphatic cording in breast cancer survivors. Rehab Oncol 24:29–34

    Google Scholar 

  27. Tilley A, Thomas-Maclean R, Kwan W (2009) Lymphatic cording or axillary web syndrome after breast cancer surgery. Can J Surg 52(4):E105–E106

    PubMed  Google Scholar 

  28. Fourie WJ, Robb KA (2009) Physiotherapy management of axillary web syndrome following breast cancer treatment: discussing the use of soft tissue techniques. Physiotherapy 95(4):314–320

    PubMed  Article  CAS  Google Scholar 

  29. Craythorne E, Benton E, Macfarlane S (2009) Axillary web syndrome or cording, a variant of Mondor disease, following axillary surgery. Arch Dermatol 145(10):1199–1200

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

This project was supported by Award R01CA139118 (AGT) and Award P50CA089393 (AGT) from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute or the National Institutes of Health.

Conflict of interest

The authors have no conflicts of interest to disclose.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alphonse G. Taghian.

Additional information

Jean O’Toole and Cynthia L. Miller are co-first authors, and have contributed equally to this manuscript.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

O’Toole, J., Miller, C.L., Specht, M.C. et al. Cording following treatment for breast cancer. Breast Cancer Res Treat 140, 105–111 (2013). https://doi.org/10.1007/s10549-013-2616-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-013-2616-9

Keywords

  • Cording
  • Axillary web syndrome
  • Functional impairment
  • Lymphedema
  • Quality of life
  • Breast surgery